Neil William Aubuchon serves as Chief Commercial Officer at Viking Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Neil William Aubuchon has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 12, 2026 involved receiving (via award) 180,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | VKTX | $0 | Award | 180,000 | $N/A | Discretionary |
Neil William Aubuchon currently holds 180,000 shares of Viking Therapeutics, Inc. (VKTX), valued at approximately $0. This represents their equity stake as Chief Commercial Officer.
Based on SEC Form 4 filings, Neil William Aubuchon has been a net neutral trader of VKTX stock. They have purchased $0 and sold $0 worth of shares.
Neil William Aubuchon's most recent insider trade was on Jan 12, 2026, when they sold 180,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted